Efficacy and safety of once-weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once-daily insulin glargine in Japanese patients with type 2 diabetes: a randomized, open-label, phase III, non-inferiority study.
Efficacy and safety of once weekly dulaglutide in combination with sulphonylurea and/or biguanide compared to once-a-day insulin glargine in Japanese patients with type 2 diabetes: a randomized, open-label, phase III, non-inferiority study